Nippon Venture Capital is the corporate venture arm of Nippon Telegraph and Telephone Corporation. The firm is focused on investing in seed, start-up and early stage companies operating in the communications, software, systems and devices, life sciences and environmental technologies sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
J Pharma | 06-Jan-2021 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
0000 & 0000000 | 16-Sep-2020 | 00000 00000 | 0000 | Consumer Finance | Generating Revenue | |
0000 0000000 | 01-Sep-2020 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 000000 000000 |
000000 | 20-Jul-2020 | 00000 00000 | 00.000 | Entertainment Software | Generating Revenue | |
000000 | 13-Mar-2020 | 00000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | 000000 000000 |
00000 000000 | 26-Dec-2019 | 0000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | 000000 000000 |
000000000 (0000000 | 22-Nov-2019 | 00000 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | |
000000 0000 | 21-Nov-2019 | 00000 00000 | 00.00 | Network Management Software | Generating Revenue | |
Next Innovation | 01-Aug-2019 | Early Stage VC | Practice Management (Healthcare) | Generating Revenue | ||
Chordia Therapeutics | 29-Mar-2019 | Early Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Kringle Pharma | 28-Dec-2020 | IPO | 00.000 |
00000 | 17-Dec-2020 | 000 | 00.000 |
00000 | 24-Jun-2020 | 000 | |
0000000 000000 | 01-Nov-2019 | 000 00 00000000 | |
00000 | 20-Aug-2019 | 000000000000000000 | |
00000000 0000 | 01-Feb-2019 | 000 00 00000000 | |
000000 000000000 | 15-Jan-2019 | 000000000000000000 | |
0000000000 | 22-Aug-2018 | 000 | 00.000 |
Bplats | 04-Apr-2018 | IPO | 00.000 |
Smart Insight | 16-Oct-2017 | Out of Business |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Minoru Tagaya | President & Board Member | 0 | 0 | 0 | Tokyo, Japan |
Koichiro Kiyonaga | Director, Managing Executive Officer and Board Member | Tokyo, Japan | |||
Reiko Mizushima | Director, Managing Executive Officer and Board Member | Tokyo, Japan | |||
Hiroyuki Kuwazono | Director, Senior Managing Executive Officer and Board Member | 0 | Tokyo, Japan | ||
Chikara Shimizu | Venture Capitalist | Tokyo, Japan |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Mitsubishi UFJ Capital | 5 | 0 |
![]() |
![]() |
|
SMBC Venture Capital | 0 |
![]() |
![]() |
||
DG Ventures (Japan) | 0 | 0 | 0 |
![]() |
![]() |
Eight Roads | 0 | 0 | 0 |
![]() |
![]() |
Jafco | 0 | 0 |
![]() |
![]() |